By Daniel Park, MS, Health Content Specialist. Medically reviewed by Dr. Maya Singh, MD, Board-Certified Internal Medicine, Obesity Medicine.
Last February, a patient named Rachel in Scottsdale called her compounding pharmacy in a mild panic. She'd found a half-used vial of tirzepatide (10 mg/mL) in the back of her refrigerator, two weeks past its beyond-use date. "I'm paying $350 a month for this stuff," she told the pharmacist. "Can I just use what's left?" The pharmacist's answer was blunt: no. Toss it.
That exchange captures the real anxiety behind this search query. People aren't asking an abstract chemistry question. They want to know if they're about to waste expensive medication, or if there's some reasonable grace period nobody's telling them about. The boring truth is that the answer loops back to dosing integrity, concentration math, and storage, not to some hidden flexibility baked into the label.
This article is part of the FormBlends ultimate guide to compounded tirzepatide and the GLP-1 Long-Term & Maintenance hub.
The Quick Version
Don't use tirzepatide past its expiration or beyond-use date. Here's the thing: peptide medications aren't like ibuprofen sitting in your medicine cabinet. Tirzepatide is a large molecule, and once the peptide degrades, you can't know what concentration remains in the vial. That means you can't accurately dose it. And with a medication where the difference between 2.5 mg and 5 mg matters clinically, "close enough" doesn't cut it.
For compounded vials specifically, the beyond-use date (BUD) is typically shorter than the expiration on a brand-name product. Compounding pharmacies set BUDs based on stability data and USP standards. Once that date passes, potency and sterility are no longer guaranteed.
Key numbers to keep in your head:
- Compounded GLP-1 dosing math: dose in mg ÷ concentration in mg/mL = volume in mL. Multiply volume by 100 to get units on a U-100 syringe.
- The unit count changes whenever the pharmacy ships a different concentration, even if your prescribed milligram dose stays the same.
- Standard tirzepatide escalation in SURMOUNT-1: 2.5 mg weekly for 4 weeks, then 5 mg, with 4-week step-ups as tolerated.
- Compounded tirzepatide is not FDA-approved. The FDA does not pre-review compounded medications for safety, effectiveness, or quality.
Why This Is Really a Dosing Question
Most people land on this page because they're holding a vial and doing math. "Can I use tirzepatide after the expiration date" is almost always a proxy for: "Is what's in this vial still the right dose?"
With a U-100 insulin syringe (the standard syringe for compounded GLP-1 products), each unit equals 0.01 mL. A 10 mg/mL vial delivers 0.1 mg per unit. A 5 mg/mL vial delivers 0.05 mg per unit.
So for a 2.5 mg dose from a 10 mg/mL vial, you draw 25 units. For the same 2.5 mg dose from a 5 mg/mL vial, you draw 50 units. The prescription is in milligrams; the syringe reads in units. The bridge between them is the concentration on the label.
When a vial is past its date, you lose confidence in that concentration. Peptides degrade. Degradation isn't uniform. You might be injecting 2.1 mg when you think you're injecting 2.5. Or you might be injecting a mix of intact tirzepatide and breakdown fragments. Neither scenario is acceptable when you're on a carefully titrated protocol.
How Tirzepatide Works (and Why Degradation Matters)
Tirzepatide is a dual GIP and GLP-1 receptor agonist, which is the headline mechanistic difference from pure GLP-1 agonists like semaglutide and liraglutide. It binds to receptors on pancreatic islet cells, central nervous system appetite centers, and gastrointestinal tract cells. The downstream effects include glucose-dependent insulin secretion, suppression of inappropriate glucagon release, slower gastric emptying, and a centrally mediated reduction in food reward and hunger.
Check your GLP-1 eligibility
Use our free BMI Calculator to see if you may qualify for provider-reviewed GLP-1 therapy.
Try the BMI Calculator →Think of it like a key that fits two locks simultaneously (GIP and GLP-1 receptors). If the key degrades, it doesn't just stop working. It might partially activate one receptor and not the other, or produce unpredictable downstream signaling. Pre-clinical and translational work suggests GIP agonism may complement GLP-1 by improving GI tolerability at higher doses and by affecting adipose-tissue physiology, but the clinical contribution of GIP activity remains an active research area.
Semaglutide and liraglutide, by comparison, act on only the GLP-1 receptor. They also differ from each other primarily in pharmacokinetics: semaglutide has a much longer half-life (enabling weekly dosing), while liraglutide requires daily injection. All three share the same vulnerability to degradation over time, especially once reconstituted or once a multi-use vial has been punctured.
What the Trials Actually Measured
The landmark trials didn't test expired product, obviously. But they do establish the dosing precision that produced the headline results, and that precision assumes intact medication at labeled concentration.
SURMOUNT-1 (Jastreboff et al., NEJM 2022) evaluated tirzepatide in adults with obesity without type 2 diabetes over 72 weeks.
SURMOUNT-4 (Aronne et al., JAMA 2024) evaluated the effect of continued versus withdrawn tirzepatide on weight maintenance.
LEADER (Marso et al., NEJM 2016) evaluated cardiovascular outcomes of liraglutide in type 2 diabetes.
Trial averages are exactly that: averages. Individual results vary, and the trials report a wide distribution around the mean. But every participant in those trials received product that met strict potency specifications. Using expired product means you're no longer operating under comparable conditions, period.
My honest take: if you're spending the money and carving out the time for weekly injections, using degraded product is like training for a marathon in shoes with no soles. You're still running, but you've undermined the whole point.
Three Real Situations and What to Do About Them
The questions driving this search cluster around a handful of scenarios. Here's how to handle each.
You found an old vial and want to know if it's still good. Check the beyond-use date. If it's past, discard the vial. Don't sniff it, hold it up to the light, or Google "does tirzepatide change color when it goes bad." Discard it. Contact your pharmacy or prescriber for a replacement.
You've been on therapy for weeks and a storage question comes up mid-cycle. Message your prescriber through the patient portal. Don't wait for your next scheduled visit, especially for anything affecting dosing or storage. Compounded tirzepatide typically needs refrigeration; if a vial sat on a counter overnight, your pharmacist can advise on whether it's still usable.
A friend asks you about your experience and wants to try your leftover vial. No. GLP-1 dosing is individualized. Concentrations vary between pharmacies. Point them toward a licensed prescriber. Sharing prescription medication is both illegal and clinically dangerous.
When to Call a Clinician (Not Tomorrow, Now)
Stop the medication and seek immediate care for: severe abdominal pain (especially radiating to the back, which can signal pancreatitis), persistent vomiting that prevents fluid intake, jaundice or right-upper-quadrant pain (possible gallbladder disease), signs of an allergic reaction (rash, facial or throat swelling, difficulty breathing), severe dehydration, or thoughts of self-harm.
Call your prescriber within 24 to 48 hours for symptoms that aren't emergent but aren't resolving: persistent nausea beyond two weeks at a stable dose, new vision changes, ongoing constipation despite hydration and fiber, or any symptom you can't explain.
For non-urgent questions about dosing, timing, or routine side effects, schedule a follow-up rather than self-adjusting. The dose-escalation schedule and injection timing are protocol-driven. Changes should be coordinated with your prescriber.
Where Expiration Dates Fit in the Bigger Picture
GLP-1 and GIP/GLP-1 therapy is one tool among several. Nutrition, resistance training, sleep, and stress management remain the four most reliably underrated inputs in real-world weight-management outcomes. An expired vial is a logistics problem. The larger variable is whether you stay on therapy long enough for it to work.
Adherence is the single largest factor separating real-world results from trial averages. Patients who maintain therapy for 12 or more months tend to retain meaningfully greater weight loss than those who discontinue within the first 90 days.
So if an expired vial creates a gap in your treatment, don't just shrug and skip a week. Call your pharmacy. Get a replacement. The disruption from a missed dose is usually minor; the disruption from quietly drifting off therapy is not.
FormBlends provides compounded tirzepatide and compounded semaglutide through licensed U.S. compounding pharmacies, paired with telehealth evaluation by an independent prescriber. The decision to start, hold, escalate, or discontinue any medication is between the patient and their prescriber.
Frequently Asked Questions
Is this question something I should discuss with a clinician? Yes. Any question that affects how a prescription medication is dosed, stored, or administered is worth raising with your prescriber. This article is general education, not a substitute for individualized clinical guidance.
What if I drew the wrong number of units last week? Stop. Do not inject again. Contact your prescriber. If the medication was already injected at the wrong dose, your prescriber will advise on next steps. Do not try to "make up" a dose without explicit instructions.
Does the unit count change if the pharmacy ships a different concentration? Yes. The unit count is derived from the concentration. A new concentration means a new unit count, even if the milligram dose is the same. Always re-read the label when you receive a new shipment.
Can I use a different syringe than the one the pharmacy provided? Use only the syringe size and type specified by your pharmacy. A U-100 insulin syringe is standard for the most common compounded GLP-1 concentrations. Substituting a different syringe changes the calibration and is a known source of dosing errors.
Is compounded tirzepatide FDA-approved? No. Compounded tirzepatide is not an FDA-approved drug. The FDA does not review compounded medications for safety, effectiveness, or quality prior to dispensing. Compounded medications are dispensed under personalized prescriptions through state-licensed pharmacies when a prescriber determines a personalized formulation is clinically appropriate.
How long does compounded tirzepatide last once refrigerated? This varies by pharmacy and formulation. The beyond-use date on your vial label is the only reliable answer. Don't assume one pharmacy's BUD applies to another pharmacy's product.
Can I freeze tirzepatide to extend its shelf life? Unless your pharmacy's label specifically says otherwise, no. Freezing can damage peptide structure and alter potency in ways that aren't visible. Follow the storage instructions on your vial exactly as printed.
Continue the Series
Important Safety Information
This article is for educational purposes only and is not medical advice. Compounded tirzepatide and compounded semaglutide are not FDA-approved drugs. The FDA does not review compounded medications for safety, effectiveness, or quality before they are sold. Compounded medications should only be used when a licensed prescriber determines a personalized formulation is clinically appropriate. Do not start, stop, or modify any prescription medication without speaking with a licensed healthcare provider. If you experience symptoms of a serious reaction, including severe abdominal pain, signs of pancreatitis, vision changes, persistent vomiting, signs of an allergic reaction, or thoughts of self-harm, seek emergency care immediately.
FormBlends sells only compounded semaglutide and compounded tirzepatide through licensed U.S. pharmacies after a telehealth evaluation by an independent prescriber. Eligibility, pricing, and formulation are determined on a case-by-case basis.
About This Article
Written by Daniel Park, MS (Health Content Specialist). Medically reviewed by Dr. Maya Singh, MD (Board-Certified Internal Medicine, Obesity Medicine). FormBlends content is reviewed by licensed U.S. clinicians prior to publication. The clinical decisions described above are general education only and should not replace individualized advice from your own healthcare provider.